Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)

A Phase 3 Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple Dose Safety and Efficacy Study of Epinastine Nasal Spray vs. Placebo in Subjects With Seasonal Allergic Rhinitis

The purpose of this study is to determine the safety and efficacy of epinastine nasal spray compared to placebo for the treatment of subjects with seasonal allergic rhinitis

Inclusion Criteria:

• A documented history of seasonal allergic rhinitis to mountain cedar or other spring pollen

Exclusion Criteria:

• Significant medical condition
• Significant nasal abnormality
• Significant cardiac condition
• Recent infection
• Use of other allergy medication during the study
• Use of asthma medication other than as-needed albuterol